本页面由Tiger Trade Technology Pte. Ltd.提供服务

Amphastar Pharmaceuticals

26.76
+0.14000.53%
盘后:26.760.00000.00%19:30 EDT
成交量:36.28万
成交额:969.13万
市值:11.38亿
市盈率:15.86
高:26.86
开:26.62
低:26.51
收:26.62
52周最高:29.52
52周最低:16.65
股本:4,253.79万
流通股本:3,052.01万
量比:0.71
换手率:1.19%
股息:- -
股息率:- -
每股收益(TTM):1.69
每股收益(LYR):2.03
净资产收益率:10.30%
总资产收益率:5.11%
市净率:1.48
市盈率(LYR):13.18

数据加载中...

2024/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

重要事件披露

Form 8-K - Current report
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]